These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 3096216

  • 1. [Induction of tumoricidal properties in human monocytes by synergism between interferon-gamma and liposome-entrapped muramyl tripeptide].
    Utsugi T, Sone S, Tandon P, Ogawara M, Shimizu E, Nii A, Nakanishi M, Shono M, Ogura T.
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3161-8. PubMed ID: 3096216
    [Abstract] [Full Text] [Related]

  • 2. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T, Sone S.
    J Immunol; 1986 Feb 01; 136(3):1117-22. PubMed ID: 3079797
    [Abstract] [Full Text] [Related]

  • 3. Synergism of recombinant human interferon gamma with liposome-encapsulated muramyl tripeptide in activation of the tumoricidal properties of human monocytes.
    Sone S, Tandon P, Utsugi T, Ogawara M, Shimizu E, Nii A, Ogura T.
    Int J Cancer; 1986 Oct 15; 38(4):495-500. PubMed ID: 3093390
    [Abstract] [Full Text] [Related]

  • 4. Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes.
    Saiki I, Sone S, Fogler WE, Kleinerman ES, Lopez-Berestein G, Fidler IJ.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6188-93. PubMed ID: 3933823
    [Abstract] [Full Text] [Related]

  • 5. Synergistic activation by recombinant mouse interferon-gamma and muramyl dipeptide of tumoricidal properties in mouse macrophages.
    Saiki I, Fidler IJ.
    J Immunol; 1985 Jul 15; 135(1):684-8. PubMed ID: 3923117
    [Abstract] [Full Text] [Related]

  • 6. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
    Fidler IJ, Fogler WE, Kleinerman ES, Saiki I.
    J Immunol; 1985 Dec 15; 135(6):4289-96. PubMed ID: 3934281
    [Abstract] [Full Text] [Related]

  • 7. Potentiating effect of muramyl dipeptide and its lipophilic analog encapsulated in liposomes on tumor cell killing by human monocytes.
    Sone S, Mutsuura S, Ogawara M, Tsubura E.
    J Immunol; 1984 Apr 15; 132(4):2105-10. PubMed ID: 6699409
    [Abstract] [Full Text] [Related]

  • 8. Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide.
    Kleinerman ES, Erickson KL, Schroit AJ, Fogler WE, Fidler IJ.
    Cancer Res; 1983 May 15; 43(5):2010-4. PubMed ID: 6831430
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo effect of doxorubicin combined with liposome-encapsulated muramyl tripeptide on canine monocyte activation.
    Shi F, MacEwen EG, Kurzman ID.
    Cancer Res; 1993 Sep 01; 53(17):3986-91. PubMed ID: 8358727
    [Abstract] [Full Text] [Related]

  • 10. [Induction of human monocyte-mediated tumor cell killing by alpha or beta interferon].
    Utsugi T, Mutsuura S, Ogawara M, Shirahama T, Ishii K, Tsubura E, Sone S.
    Gan To Kagaku Ryoho; 1985 May 01; 12(5):1105-10. PubMed ID: 3994398
    [Abstract] [Full Text] [Related]

  • 11. Potential value of liposomes containing muramyl dipeptide for augmenting the tumoricidal activity of human alveolar macrophages.
    Sone S, Tachibana K, Shono M, Ogushi F, Tsubura E.
    J Biol Response Mod; 1984 May 01; 3(2):185-94. PubMed ID: 6726281
    [Abstract] [Full Text] [Related]

  • 12. Lack of production of interleukin 1 by human blood monocytes activated to the antitumor state by liposome-encapsulated muramyl tripeptide.
    Tandon P, Utsugi T, Sone S.
    Cancer Res; 1986 Oct 01; 46(10):5039-44. PubMed ID: 3489519
    [Abstract] [Full Text] [Related]

  • 13. The activation of tumoricidal properties in human blood monocytes by muramyl dipeptide requires specific intracellular interaction.
    Fogler WE, Fidler IJ.
    J Immunol; 1986 Mar 15; 136(6):2311-7. PubMed ID: 2936824
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant therapy for melanoma in dogs: results of randomized clinical trials using surgery, liposome-encapsulated muramyl tripeptide, and granulocyte macrophage colony-stimulating factor.
    MacEwen EG, Kurzman ID, Vail DM, Dubielzig RR, Everlith K, Madewell BR, Rodriguez CO, Phillips B, Zwahlen CH, Obradovich J, Rosenthal RC, Fox LE, Rosenberg M, Henry C, Fidel J.
    Clin Cancer Res; 1999 Dec 15; 5(12):4249-58. PubMed ID: 10632367
    [Abstract] [Full Text] [Related]

  • 15. Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde.
    Okubo A, Sone S, Tanaka M, Ogura T.
    Cancer Res; 1989 Jan 15; 49(2):265-70. PubMed ID: 2463072
    [Abstract] [Full Text] [Related]

  • 16. In vitro synergic effect of interferon gamma combined with liposomes containing muramyl tripeptide on human monocyte cytotoxicity against fresh allogeneic and autologous tumor cells.
    Galligioni E, Santarosa M, Favaro D, Spada A, Talamini R, Quaia M.
    Tumori; 1994 Oct 31; 80(5):385-91. PubMed ID: 7839471
    [Abstract] [Full Text] [Related]

  • 17. Induction of tumoricidal activity in isolated rat liver macrophages by liposomes containing recombinant rat gamma-interferon supplemented with lipopolysaccharide or muramyldipeptide.
    Stukart MJ, Rijnsent A, Roos E.
    Cancer Res; 1987 Jul 15; 47(14):3880-5. PubMed ID: 3109735
    [Abstract] [Full Text] [Related]

  • 18. Induction by interferon-alpha of tumoricidal activity of adherent mononuclear cells from human blood: monocytes as responder and effector cells.
    Sone S, Utsugi T, Shirahama T, Ishii K, Mutsuura S, Ogawara M.
    J Biol Response Mod; 1985 Apr 15; 4(2):134-40. PubMed ID: 3998764
    [Abstract] [Full Text] [Related]

  • 19. Comparative interaction of free and liposome-encapsulated nor-muramyl dipeptide or muramyl tripeptide phosphatidylethanolamine (3H-labelled) with human blood monocytes.
    Fogler WE, Fidler IJ.
    Int J Immunopharmacol; 1987 Apr 15; 9(2):141-50. PubMed ID: 3583507
    [Abstract] [Full Text] [Related]

  • 20. A dried preparation of liposomes containing muramyl tripeptide phosphatidylethanolamine as a potent activator of human blood monocytes to the antitumor state.
    Sone S, Utsugi T, Tandon P, Ogawara M.
    Cancer Immunol Immunother; 1986 Apr 15; 22(3):191-6. PubMed ID: 3731204
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.